TREEWAY
Treeway has been formed by the words tree of life and pathway of a disease, for the founders the symbolic way towards a cure. We foresee that medication, research and care will change dramatically in the coming decades and patients will become an essential part of this process in their pursuit for cures in rare and common diseases. Everyone can make a difference and our slogan "one man can and will find a way, why not be that man?" underpins our drive. It is our mission to speed up research for ALS in collaboration with academic and research centers around the globe. We thrive to inspire them with our drive for accelerating therapies and drug development for ALS and aim to have new therapies in the market before the end of 2014.
TREEWAY
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
Rotterdam, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.treeway.nl
Total Employee:
1+
Status:
Active
Contact:
+31 88 873 3939
Email Addresses:
[email protected]
Total Funding:
50 K EUR
Technology used in webpage:
WordPress 6.4 Infopact
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Treeway
Official Site Inspections
http://www.treeway.nl Semrush global rank: 11.36 M Semrush visits lastest month: 162
- Host name: server3.qprivate.nl
- IP address: 178.255.196.119
- Location: Rotterdam Netherlands
- Latitude: 51.9286
- Longitude: 4.4215
- Timezone: Europe/Amsterdam
- Postal: 3044
More informations about "Treeway"
About us - Treeway
Treeway is continuously assessing several research lines to validate drugable targets. Patient impact. Treeway is a patient-founded and patient-inspired company. Therefore, we are sensitive to the patients’ needs in the …See details»
Treeway - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +31 88 873 3939 Treeway has been formed by the words tree of life and pathway of a disease, for the founders the symbolic way towards a cure.See details»
Leadership - Treeway
Currently, Treeway’s research and development’s pipeline consists of three programs for the ALS, Alzheimer’s disease and Ophtalmology indications. The ALS and Alzheimer’s disease …See details»
Treeway: Contact Details and Business Profile - RocketReach
Treeway is a clinical-stage biotech company developing therapy for ALS, Alzheimer's Disease and other neurodegenerative diseases. ... NL Phone +31 88 873 3929: Technologies: …See details»
Treeway Company Profile - Office Locations, Competitors ... - Craft
Treeway has 5 employees at their 1 location and $55.78 k in total funding,. See insights on Treeway including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Startup Treeway About to Make a Big Impact on ALS Treatment
Jun 24, 2022 Biotech startup Treeway received an innovation credit from the Netherlands Enterprise Agency (RVO). Thanks to this credit, TW001 reached the last phase in its clinical …See details»
Treeway BV (Treeway BV) - 药物管线_专利_临床试验_投融营收_最 …
Treeway CEO Inez de Greef said: “This important therapy has shown very encouraging results in all studies to date. “We look forward to further results from the ADORE study and then working …See details»
Our team - Treeway
Currently, Treeway’s research and development’s pipeline consists of three programs for the ALS, Alzheimer’s disease and Ophtalmology indications. The ALS and Alzheimer’s disease …See details»
Biotechbedrijf Treeway is stap dichterbij medicijn tegen ALS
Het Spaanse farmabedrijf Ferrer neemt vervolgonderzoek naar ALS-medicijn van Treeway op zich. Treeway ontwikkelde een poedervorm van een medicijn dat in Japan en de VS al is …See details»
Treeway Company Overview, Contact Details & Competitors | LeadIQ
Learn more about Treeway's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Treeway Company Information - Funding, Investors, and More
Treeway https://treeway.nl. Platform accelerating therapy development for ALS (Amyotrophic Lateral Sclerosis). Get the top 10 companies of the week in your email, every Tuesday. …See details»
Vereniging Innovatieve Geneesmiddelen | ‘Ontwikkeling …
Mar 7, 2024 De Greef werd aangesteld als CEO van Treeway. Ze startte met het ontwikkelen van Treeway tot biotech-bedrijf. ‘Aan een geneesmiddel ontwikkelen, zit een hoog risico en er …See details»
Treeway TW001 - Stichting ALS Nederland
Daarnaast werkt Treeway in Nederland o.a. ook samen met het LACDR, verbonden aan de universiteit Leiden. Indien de studie aantoont dat TW001 de ziekte kan vertragen, zal Treeway …See details»
Treeway announces first patient enrolled in the Phase 2a ASURE …
Mar 6, 2023 More information available at https://treeway.nl/. Treeway, Therapy development inspired by patients. ... ADDF is a nonprofit organization leading the way in Alzheimer’s …See details»
Treeway ‘Voor ALS-patiënten is alleen afremmen al heel belangrijk’
Jun 26, 2016 Treeway wil de slopende spierziekte ALS een halt toeroepen, en als het kan genezen. Maar ook de weg naar een nieuw geneesmiddel is lang en zwaar, zo merkt oprichter …See details»
Treeway - Brain Research Center
Meer weten over het Treeway onderzoek bij Brain Research Center? Alle informatie vindt u hier op een rij.See details»
Mission and Vision - Treeway
Treeway’s mission is rooted in the story of Bernard Muller and Robbert Jan Stuit, two successful Dutch businessmen who were diagnosed with ALS in 2010 and 2011. Realizing that there was …See details»
Treeway prepares phase 3 study for TW001 to treat ALS
May 29, 2018 Treeway, a biotech company developing therapies against amyotrophic lateral sclerosis (ALS), announced the completion of its Phase I trial of lead program TW001, an oral …See details»
Awareness - Treeway
Currently, Treeway’s research and development’s pipeline consists of three programs for the ALS, Alzheimer’s disease and Ophtalmology indications. The ALS and Alzheimer’s disease …See details»